As the poultry industry heads into the second quarter of 2026, one thing is becoming clearer: intestinal health is no longer being treated as a narrow technical topic. It is increasingly being discussed as a central part of flock resilience, disease management and production efficiency. That shift is reflected in the agenda for the 9th International Conference on Poultry Intestinal Health, set to take place in Istanbul, Turkiye, from April 22 to April 24, 2026. 

According to the official conference website, ICPIH 2026 has already drawn more than 1,200 confirmed attendees, suggesting continued global interest in how gut health is shaping modern poultry production. The meeting is being organized around a broad scientific program that goes well beyond nutrition alone, covering intestinal microbiome research, infectious disease pathogenesis and control, in vitro and in vivo gut health models, gut health markers and diagnostics, dietary additives, and innovative management solutions. 

That breadth matters. In poultry systems, gut health increasingly sits at the intersection of biology and economics. A weaker intestinal environment can affect feed conversion, growth consistency, immune response and susceptibility to disease, while stronger gut resilience can support more stable performance under commercial conditions. The ICPIH 2026 program reflects that wider industry reality by linking microbiome science and host-pathogen interactions with practical topics such as early feeding, diagnostics and on-farm management. 

The program itself points to the main questions now driving the discussion. Day one includes sessions on the intestinal microbiome in poultry, the pathogenesis and control of infectious diseases, and models to study gut health. Day two moves into dietary additives, gut health markers and diagnostics, and innovative management solutions, including on-farm hatching and early feeding. Across the three days, the structure suggests an industry trying to connect scientific advances with tools that can be applied in commercial production. 

There is also a clear signal in the scale of industry involvement. The official ICPIH site lists a wide range of partners and sponsors from across the poultry health, nutrition and diagnostics landscape, indicating that intestinal health remains a high-priority area for companies working on feed additives, vaccines, microbiome solutions, testing and farm performance support. 

Taken together, ICPIH 2026 looks less like a niche scientific gathering and more like a barometer for where poultry health strategy is heading. Gut health is being treated not simply as a feed issue, but as part of a broader effort to improve disease resilience, reduce performance volatility and protect the economics of production.